Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Christopher Boerner
Pharma
Bristol Myers CEO pledges to 'cast a broad net' in dealmaking
BMS completed $30 billion worth of deals in the past two years. Still, “business development remains a top priority,” CEO Chris Boerner said.
Angus Liu
Jan 12, 2026 4:28pm
Big Pharma CEOs offer China renewed interest, policy advice
Mar 26, 2024 11:46am
BMS scouts for M&A deals amid multiple new launches: CEO
Apr 27, 2023 1:13pm
BMS' Caforio to hand CEO baton to commercial chief Boerner
Apr 26, 2023 5:03pm
BMS touts 'diversified' new launches, M&A as 'top priority'
Jan 9, 2023 3:20pm
Bristol Myers hits Abecma CAR-T manufacturing bottleneck
Jul 28, 2021 10:48am
